ProShare Advisors’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $171K | Sell |
|
|||||
|
2025
Q1 | $204K | Sell |
|
|||||
|
2024
Q4 | $158K | Sell |
|
|||||
|
2024
Q3 | $201K | Buy |
|
|||||
|
2024
Q2 | $60.7K | Sell |
|
|||||
|
2024
Q1 | $74.2K | Buy |
|
|||||
|
2023
Q4 | $72.5K | Buy |
|
|||||
|
2023
Q3 | $48.9K | Buy |
|
|||||
|
2023
Q2 | $68.6K | Buy |
|
|||||
|
2023
Q1 | $40.8K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $41K | Buy |
|
|||||
|
2022
Q2 | $39K | Buy |
|
|||||
|
2022
Q1 | $36K | Sell |
|
|||||
|
2021
Q4 | $51K | Buy |
|
|||||
|
2021
Q3 | $35K | Buy |
|
|||||
|
2021
Q2 | $49K | Sell |
|
|||||
|
2021
Q1 | $92K | Buy |
|
|||||
|
2020
Q4 | $87K | Buy |
|
|||||
|
2020
Q3 | $78K | Buy |
|
|||||
|
2020
Q2 | $29K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $102K | Buy |
|
|||||
|
2019
Q2 | $115K | Sell |
|
|||||
|
2019
Q1 | $114K | Buy |
|